Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · J.P. Morgan

JPMorgan Mid Cap Equity Fund Class C (JMCCX)

Ticker JMCCX · · Holdings as of Jun 30, 2026

Expense ratio
1.54%$154/yr per $10k
5-yr return
+6.4%annualized
1-yr return
+4.3%as of Dec 2025
Net assets
$6.2Ball share classes
Holdings
208

Bottom line

Is JMCCX a good fund? The bottom line

JMCCX is the Class C share class of JPMorgan Mid Cap Equity Fund, a managed mid-cap mutual fund from J.P. Morgan.

Its expense ratio is 1.54% — about $154 a year on every $10,000 invested, more expensive than 88% of mid-cap funds we track.

It returned +4.3% over one year, +6.4% a year over five years, +9.9% a year over ten (as of Dec 31, 2025, per its prospectus).

With $6.2 billion in net assets and 208 holdings, its largest position is JPMorgan Prime Money Market Fund (2.9%) and the top 10 make up 15.2% of the portfolio.

What stands out

  • Broadly diversified (208 holdings)
  • No front-end sales load

What to watch

  • Expensive for its category (1.54%)
  • 12b-1 marketing fee of 0.75% a year

Updated Nov 19, 2026

What JMCCX invests in

The Funds objective is long-term capital growth.

Under normal circumstances, the Fund invests at least 80% of its Assets in equity securities of mid cap companies. Equity securities represent an ownership interest in the issuer. Mid cap companies are companies with market capitalizations equal to those within the universe of the Russell Midcap Index at the time of purchase. As of the reconstitution of the Russell Midcap Index on September 30, 2026, the market capitalizations of the companies in the index ranged from $1.76 billion to $251.61 billion. In implementing its main strategies, the Fund invests primarily in common stocks and real estate investment trusts (REITs). Assets means net assets, plus the amount of borrowings for investment purposes. Derivatives, which are instruments that have a value based on another instrument, exchange rate or index, may be used as substitutes for securities in which the Fund can invest. To the…

From the fund's prospectus (filed Oct 27, 2026).

JMCCX performance

Average annual total returns
1 yr5 yr10 yr
JMCCX+4.3%+6.4%+9.9%
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full JMCCX performance history →

What JMCCX costs

On a $10,000 investment, JMCCX's 1.54% expense ratio costs about $154 a year. The prospectus estimates $1,878 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full JMCCX fee table →

JMCCX top 10 holdings

#Holding% of fund
1JPMorgan Prime Money Market Fund2.89%
2IQVIA Holdings, Inc.1.75%
3MKS, Inc.1.73%
4AMETEK, Inc.1.43%
5Cencora, Inc.1.39%
6Jabil, Inc.1.37%
7Silgan Holdings, Inc.1.21%
8Healthpeak Properties, Inc.1.20%
9Fidelity National Information Services, Inc.1.12%
10Ameriprise Financial, Inc.1.11%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 15.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to JMCCX

More funds like JMCCX →

JMCCX FAQ

What is the expense ratio of JMCCX?
JMCCX's expense ratio is 1.54%, which works out to about $154 a year for every $10,000 invested. The prospectus estimates total costs of $1,878 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is JMCCX a good investment?
It depends on your goals, but the data points to: broadly diversified (208 holdings); no front-end sales load; expensive for its category (1.54%); 12b-1 marketing fee of 0.75% a year. This is general information, not personalized advice.
What does JMCCX hold?
JMCCX's largest holdings are JPMorgan Prime Money Market Fund (2.9%), IQVIA Holdings, Inc. (1.8%), MKS, Inc. (1.7%), AMETEK, Inc. (1.4%), Cencora, Inc. (1.4%). It holds 208 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is JMCCX's 5-year return?
JMCCX returned +6.4% a year over the five years ending Dec 31, 2025, and +9.9% a year over ten years. Past performance does not guarantee future results.
Does JMCCX have a sales load?
No. JMCCX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages JMCCX?
JMCCX is offered by J.P. Morgan through JPMorgan Trust I.